United Therapeutics (UTHR) Stock Price & Financial Analysis
United Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About United Therapeutics
What is the current stock price for UTHR?
As of the latest trading session, UTHR stock trades at $566.80. The 52-week range is $272.12–$609.35, with a day range of $560.23–$572.45.
What is the P/E ratio for UTHR?
United Therapeutics's trailing P/E ratio is 20.4, meaning investors pay $20.4 for every $1 of annual earnings. The forward P/E is 18.3, reflecting analyst expectations for future earnings. United Therapeutics operates in the Healthcare sector.
Does UTHR pay dividends?
United Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for UTHR?
Based on 9 analysts, the consensus for UTHR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of UTHR?
United Therapeutics's market capitalization is $27.15B, classifying it as a large-cap company. United Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.